Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion

Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders 2008-01, Vol.23 (1), p.145-146
Main Authors: Meiler, Birgit, Andrich, Jürgen, Müller, Thomas
Format: Article
Language:English
Subjects:
Administration, Oral
Aged
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Drug Therapy, Combination
Duodenum
Female
Humans
Infusions, Parenteral
Jejunostomy
Levodopa - administration & dosage
Levodopa - therapeutic use
levodopa infusion
Male
Medical sciences
Neurology
Neuropharmacology
Parkinson Disease - drug therapy
Parkinson's disease
Pharmacology. Drug treatments
Time Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4570-23f2d5294348525662b2c5fb99af24fd119f62b480d8fe5ab1a6bfa46bad01cf3
cites cdi_FETCH-LOGICAL-c4570-23f2d5294348525662b2c5fb99af24fd119f62b480d8fe5ab1a6bfa46bad01cf3
container_end_page 146
container_issue 1
container_start_page 145
container_title Movement disorders
container_volume 23
creator Meiler, Birgit
Andrich, Jürgen
Müller, Thomas
description Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option. © 2007 Movement Disorder Society
doi_str_mv 10.1002/mds.21800
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70254172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21149536</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4570-23f2d5294348525662b2c5fb99af24fd119f62b480d8fe5ab1a6bfa46bad01cf3</originalsourceid><addsrcrecordid>eNqF0U1v1DAQBmALgei2cOAPIF9A6iGtx44T54i2HyC1IJUibliT2KaGxA520nb_PYFdyglxsmQ974z0DiEvgB0BY_x4MPmIg2LsEVmBFFAoLuvHZMWUkoUAJffIfs7fGAOQUD0le1A3qq6kWJEvVzh6Q_Odn7ob6lIcaEzYUwyTHzF99yHH4DHQLg6tDzj5GKhJ81c63diE44ZOkZo5GhuWVG9vo4kjUh_cnBf6jDxx2Gf7fPcekE9np9frt8XFh_N36zcXRVfKmhVcOG4kb0pRKsllVfGWd9K1TYOOl84ANG75KxUzylmJLWDVOiyrFg2DzokD8no7d0zxx2zzpAefO9v3GGycs64ZlyXU_L-QA5SNFNUCD7ewSzHnZJ0ekx8wbTQw_at1vbSuf7e-2Je7oXM7WPNX7mpewKsdwNxh7xKGzucHxxmTQtXl4o637s73dvPvjfry5OOf1cU24fNk7x8Sy-V0VYta6s_vz_X68hoaxU70lfgJuZmpCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21149536</pqid></control><display><type>article</type><title>Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Meiler, Birgit ; Andrich, Jürgen ; Müller, Thomas</creator><creatorcontrib>Meiler, Birgit ; Andrich, Jürgen ; Müller, Thomas</creatorcontrib><description>Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option. © 2007 Movement Disorder Society</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.21800</identifier><identifier>PMID: 17987653</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Administration, Oral ; Aged ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Drug Therapy, Combination ; Duodenum ; Female ; Humans ; Infusions, Parenteral ; Jejunostomy ; Levodopa - administration &amp; dosage ; Levodopa - therapeutic use ; levodopa infusion ; Male ; Medical sciences ; Neurology ; Neuropharmacology ; Parkinson Disease - drug therapy ; Parkinson's disease ; Pharmacology. Drug treatments ; Time Factors</subject><ispartof>Movement disorders, 2008-01, Vol.23 (1), p.145-146</ispartof><rights>Copyright © 2007 Movement Disorder Society</rights><rights>2008 INIST-CNRS</rights><rights>2007 Movement Disorder Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4570-23f2d5294348525662b2c5fb99af24fd119f62b480d8fe5ab1a6bfa46bad01cf3</citedby><cites>FETCH-LOGICAL-c4570-23f2d5294348525662b2c5fb99af24fd119f62b480d8fe5ab1a6bfa46bad01cf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20053874$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17987653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meiler, Birgit</creatorcontrib><creatorcontrib>Andrich, Jürgen</creatorcontrib><creatorcontrib>Müller, Thomas</creatorcontrib><title>Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</title><title>Movement disorders</title><addtitle>Mov. Disord</addtitle><description>Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option. © 2007 Movement Disorder Society</description><subject>Administration, Oral</subject><subject>Aged</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Drug Therapy, Combination</subject><subject>Duodenum</subject><subject>Female</subject><subject>Humans</subject><subject>Infusions, Parenteral</subject><subject>Jejunostomy</subject><subject>Levodopa - administration &amp; dosage</subject><subject>Levodopa - therapeutic use</subject><subject>levodopa infusion</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson's disease</subject><subject>Pharmacology. Drug treatments</subject><subject>Time Factors</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqF0U1v1DAQBmALgei2cOAPIF9A6iGtx44T54i2HyC1IJUibliT2KaGxA520nb_PYFdyglxsmQ974z0DiEvgB0BY_x4MPmIg2LsEVmBFFAoLuvHZMWUkoUAJffIfs7fGAOQUD0le1A3qq6kWJEvVzh6Q_Odn7ob6lIcaEzYUwyTHzF99yHH4DHQLg6tDzj5GKhJ81c63diE44ZOkZo5GhuWVG9vo4kjUh_cnBf6jDxx2Gf7fPcekE9np9frt8XFh_N36zcXRVfKmhVcOG4kb0pRKsllVfGWd9K1TYOOl84ANG75KxUzylmJLWDVOiyrFg2DzokD8no7d0zxx2zzpAefO9v3GGycs64ZlyXU_L-QA5SNFNUCD7ewSzHnZJ0ekx8wbTQw_at1vbSuf7e-2Je7oXM7WPNX7mpewKsdwNxh7xKGzucHxxmTQtXl4o637s73dvPvjfry5OOf1cU24fNk7x8Sy-V0VYta6s_vz_X68hoaxU70lfgJuZmpCQ</recordid><startdate>200801</startdate><enddate>200801</enddate><creator>Meiler, Birgit</creator><creator>Andrich, Jürgen</creator><creator>Müller, Thomas</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200801</creationdate><title>Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</title><author>Meiler, Birgit ; Andrich, Jürgen ; Müller, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4570-23f2d5294348525662b2c5fb99af24fd119f62b480d8fe5ab1a6bfa46bad01cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Administration, Oral</topic><topic>Aged</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Drug Therapy, Combination</topic><topic>Duodenum</topic><topic>Female</topic><topic>Humans</topic><topic>Infusions, Parenteral</topic><topic>Jejunostomy</topic><topic>Levodopa - administration &amp; dosage</topic><topic>Levodopa - therapeutic use</topic><topic>levodopa infusion</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson's disease</topic><topic>Pharmacology. Drug treatments</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meiler, Birgit</creatorcontrib><creatorcontrib>Andrich, Jürgen</creatorcontrib><creatorcontrib>Müller, Thomas</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meiler, Birgit</au><au>Andrich, Jürgen</au><au>Müller, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov. Disord</addtitle><date>2008-01</date><risdate>2008</risdate><volume>23</volume><issue>1</issue><spage>145</spage><epage>146</epage><pages>145-146</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><abstract>Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option. © 2007 Movement Disorder Society</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17987653</pmid><doi>10.1002/mds.21800</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0885-3185
ispartof Movement disorders, 2008-01, Vol.23 (1), p.145-146
issn 0885-3185
1531-8257
language eng
recordid cdi_proquest_miscellaneous_70254172
source Wiley-Blackwell Read & Publish Collection
subjects Administration, Oral
Aged
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Drug Therapy, Combination
Duodenum
Female
Humans
Infusions, Parenteral
Jejunostomy
Levodopa - administration & dosage
Levodopa - therapeutic use
levodopa infusion
Male
Medical sciences
Neurology
Neuropharmacology
Parkinson Disease - drug therapy
Parkinson's disease
Pharmacology. Drug treatments
Time Factors
title Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A51%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rapid%20switch%20from%20oral%20antiparkinsonian%20combination%20drug%20therapy%20to%20duodenal%20levodopa%20infusion&rft.jtitle=Movement%20disorders&rft.au=Meiler,%20Birgit&rft.date=2008-01&rft.volume=23&rft.issue=1&rft.spage=145&rft.epage=146&rft.pages=145-146&rft.issn=0885-3185&rft.eissn=1531-8257&rft_id=info:doi/10.1002/mds.21800&rft_dat=%3Cproquest_cross%3E21149536%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4570-23f2d5294348525662b2c5fb99af24fd119f62b480d8fe5ab1a6bfa46bad01cf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=21149536&rft_id=info:pmid/17987653&rfr_iscdi=true